Literature DB >> 12513924

Cytotoxic T lymphocytes and neutralizing antibody in the control of equine infectious anemia virus.

Travis C McGuire1, Darrilyn G Fraser, Robert H Mealey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12513924     DOI: 10.1089/088282402320914476

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


× No keyword cloud information.
  5 in total

1.  Rhodococcus equi-infected macrophages are recognized and killed by CD8+ T lymphocytes in a major histocompatibility complex class I-unrestricted fashion.

Authors:  Kristin M Patton; Travis C McGuire; Darrilyn G Fraser; Stephen A Hines
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

2.  A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.

Authors:  Robert H Mealey; Jae-Hyung Lee; Steven R Leib; Matt H Littke; Travis C McGuire
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

4.  Cloning and large-scale expansion of epitope-specific equine cytotoxic T lymphocytes using an anti-equine CD3 monoclonal antibody and human recombinant IL-2.

Authors:  Robert H Mealey; Matt H Littke; Steven R Leib; William C Davis; Travis C McGuire
Journal:  Vet Immunol Immunopathol       Date:  2007-04-08       Impact factor: 2.046

5.  Viral load and clinical disease enhancement associated with a lentivirus cytotoxic T lymphocyte vaccine regimen.

Authors:  Robert H Mealey; Steven R Leib; Matt H Littke; Bettina Wagner; David W Horohov; Travis C McGuire
Journal:  Vaccine       Date:  2009-02-24       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.